title: Some objective considerations for the use of heparins and recombinant hirudin in percutaneous transluminal coronary angioplasty.
authors.affiliation: Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153.
authors.forename: J
authors.initials: J
authors.lastname: Fareed
authors.forename: J M
authors.initials: JM
authors.lastname: Walenga
authors.forename: F
authors.initials: F
authors.lastname: Leya
authors.forename: P
authors.initials: P
authors.lastname: Bacher
authors.forename: D
authors.initials: D
authors.lastname: Hoppensteadt
authors.forename: H
authors.initials: H
authors.lastname: Messmore
authors.forename: R
authors.initials: R
authors.lastname: Pifarre
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D006493:Heparin / Q000627:therapeutic use*; D024764:Hirudin Therapy; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D006493:Heparin